Tobacco Induced Diseases · 2014 · 36 citations · 0 references
Public HealthPharmacologyPulmonary Function TestingPulmonologyTobacco ControlNicotine PharmacologySmoking CessationTobacco UseTobacco Use CessationAirway ConductanceElectronic CigarettesLung Function DeclineLung Function TestingSmoking-related Lung DiseaseSpecific Airway ResistanceSpirometric Lung VolumesTobacco Smoking
Materials and methods We extended our protocol in a larger group of never smokers and in smokers. We implemented the same protocol with a nicotine free e-cig in a group of never smokers. We studied 60 subjects before and after smoking an e-cig containing 11mg nicotine (Group A). Group A: 9 never smokers and 51 smokers (24 had no overt airways disease, 11 asthma, 16 COPD). Another group of 10 never smokers used a nicotine free e-cig (Group B). Lung function assessed pre and post e-cig use including lung volumes, airway resistance (Raw), specific airway conductance (sGaw) and the slope of phase III. The same brand of e-cig used in both groups, with 11 and 0mg of nicotine.